Virology—the path forward

Angela L. Rasmussen; Gigi K. Gronvall; Anice C. Lowen; Felicia Goodrum; James Alwine; Kristian G. Andersen; Simon J. Anthony; Joel Baines; Arinjay Banerjee; Andrew J. Broadbent; Christopher B. Brooke; Samuel K. Campos; Patrizia Caposio; Arturo Casadevall; Gary C. Chan; Anna R. Cliffe; Donna Collins-McMillen; Nancy Connell; Blossom Damania; Matthew D. Daugherty; Kari Debbink; Terence S. Dermody; Daniel DiMaio; W. Paul Duprex; Michael Emerman; Denise A. Galloway; Robert F. Garry; Stephen A. Goldstein; Alexander L. Greninger; Amy L. Hartman; Brenda G. Hogue; Stacy M. Horner; Peter J. Hotez; Jae U. Jung; Jeremy P. Kamil; Stephanie M. Karst; Lou Laimins; Seema S. Lakdawala; Igor Landais; Michael Letko; Brett Lindenbach; Shan Lu Liu; Micah Luftig; Grant McFadden; Andrew Mehle; Juliet Morrison; Anne Moscona; Elke Mühlberger; Joshua Munger; Karl Münger; Eain Murphy; Christopher J. Neufeldt; Janko Z. Nikolich; Christine M. O'Connor; Andrew Pekosz; Sallie R. Permar; Julie K. Pfeiffer; Saskia V. Popescu; John G. Purdy; Vincent R. Racaniello; Charles M. Rice; Jonathan A. Runstadler; Martin J. Sapp; Rona S. Scott; Gregory A. Smith; Erin M. Sorrell; Emily Speranza; Daniel Streblow; Scott A. Tibbetts; Zsolt Toth; Koenraad Van Doorslaer; Susan R. Weiss; Elizabeth A. White; Timothy M. White; Christiane E. Wobus; Michael Worobey; Satoko Yamaoka; Andrew Yurochko

doi:10.1128/jvi.00074-24

Virology—the path forward

Angela L. Rasmussen
, Gigi K. Gronvall
, Anice C. Lowen
, Felicia Goodrum
, James Alwine
, Kristian G. Andersen
, Simon J. Anthony
, Joel Baines
, Arinjay Banerjee
, Andrew J. Broadbent
, Christopher B. Brooke
, Samuel K. Campos
, Patrizia Caposio
, Arturo Casadevall
, Gary C. Chan
, Anna R. Cliffe
, Donna Collins-McMillen
, Nancy Connell
, Blossom Damania
, Matthew D. Daugherty

Kari Debbink, Terence S. Dermody, Daniel DiMaio, W. Paul Duprex, Michael Emerman, Denise A. Galloway, Robert F. Garry, Stephen A. Goldstein, Alexander L. Greninger, Amy L. Hartman, Brenda G. Hogue, Stacy M. Horner, Peter J. Hotez, Jae U. Jung, Jeremy P. Kamil, Stephanie M. Karst, Lou Laimins, Seema S. Lakdawala, Igor Landais, Michael Letko, Brett Lindenbach, Shan Lu Liu, Micah Luftig, Grant McFadden, Andrew Mehle, Juliet Morrison, Anne Moscona, Elke Mühlberger, Joshua Munger, Karl Münger, Eain Murphy, Christopher J. Neufeldt, Janko Z. Nikolich, Christine M. O'Connor, Andrew Pekosz, Sallie R. Permar, Julie K. Pfeiffer, Saskia V. Popescu, John G. Purdy, Vincent R. Racaniello, Charles M. Rice, Jonathan A. Runstadler, Martin J. Sapp, Rona S. Scott, Gregory A. Smith, Erin M. Sorrell, Emily Speranza, Daniel Streblow, Scott A. Tibbetts, Zsolt Toth, Koenraad Van Doorslaer, Susan R. Weiss, Elizabeth A. White, Timothy M. White, Christiane E. Wobus, Michael Worobey, Satoko Yamaoka, Andrew Yurochko

Research output: Contribution to journal › Review article › peer-review

Abstract

In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.

Original language	English (US)
Journal	Journal of virology
Volume	98
Issue number	3
DOIs	https://doi.org/10.1128/jvi.00074-24
State	Published - Mar 2024
Externally published	Yes

Bibliographical note

Publisher Copyright:
Copyright © 2024 American Society for Microbiology. All Rights Reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

biosafety
COVID-19
emergence
oversight
SARS-CoV-2
virology

Publisher link

10.1128/jvi.00074-24

Find It

Find It at U of M Libraries

Cite this

Rasmussen, A. L., Gronvall, G. K., Lowen, A. C., Goodrum, F., Alwine, J., Andersen, K. G., Anthony, S. J., Baines, J., Banerjee, A., Broadbent, A. J., Brooke, C. B., Campos, S. K., Caposio, P., Casadevall, A., Chan, G. C., Cliffe, A. R., Collins-McMillen, D., Connell, N., Damania, B., ... Yurochko, A. (2024). Virology—the path forward. Journal of virology, 98(3). https://doi.org/10.1128/jvi.00074-24

Rasmussen, AL, Gronvall, GK, Lowen, AC, Goodrum, F, Alwine, J, Andersen, KG, Anthony, SJ, Baines, J, Banerjee, A, Broadbent, AJ, Brooke, CB, Campos, SK, Caposio, P, Casadevall, A, Chan, GC, Cliffe, AR, Collins-McMillen, D, Connell, N, Damania, B, Daugherty, MD, Debbink, K, Dermody, TS, DiMaio, D, Duprex, WP, Emerman, M, Galloway, DA, Garry, RF, Goldstein, SA, Greninger, AL, Hartman, AL, Hogue, BG, Horner, SM, Hotez, PJ, Jung, JU, Kamil, JP, Karst, SM, Laimins, L, Lakdawala, SS, Landais, I, Letko, M, Lindenbach, B, Liu, SL, Luftig, M, McFadden, G, Mehle, A, Morrison, J, Moscona, A, Mühlberger, E, Munger, J, Münger, K, Murphy, E, Neufeldt, CJ, Nikolich, JZ, O'Connor, CM, Pekosz, A, Permar, SR, Pfeiffer, JK, Popescu, SV, Purdy, JG, Racaniello, VR, Rice, CM, Runstadler, JA, Sapp, MJ, Scott, RS, Smith, GA, Sorrell, EM, Speranza, E, Streblow, D, Tibbetts, SA, Toth, Z, Van Doorslaer, K, Weiss, SR, White, EA, White, TM, Wobus, CE, Worobey, M, Yamaoka, S & Yurochko, A 2024, 'Virology—the path forward', Journal of virology, vol. 98, no. 3. https://doi.org/10.1128/jvi.00074-24

@article{03517dd831b24d16b722eb2a68a8d85f,

title = "Virology{\textemdash}the path forward",

abstract = "In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.",

keywords = "biosafety, COVID-19, emergence, oversight, SARS-CoV-2, virology",

author = "Rasmussen, \{Angela L.\} and Gronvall, \{Gigi K.\} and Lowen, \{Anice C.\} and Felicia Goodrum and James Alwine and Andersen, \{Kristian G.\} and Anthony, \{Simon J.\} and Joel Baines and Arinjay Banerjee and Broadbent, \{Andrew J.\} and Brooke, \{Christopher B.\} and Campos, \{Samuel K.\} and Patrizia Caposio and Arturo Casadevall and Chan, \{Gary C.\} and Cliffe, \{Anna R.\} and Donna Collins-McMillen and Nancy Connell and Blossom Damania and Daugherty, \{Matthew D.\} and Kari Debbink and Dermody, \{Terence S.\} and Daniel DiMaio and Duprex, \{W. Paul\} and Michael Emerman and Galloway, \{Denise A.\} and Garry, \{Robert F.\} and Goldstein, \{Stephen A.\} and Greninger, \{Alexander L.\} and Hartman, \{Amy L.\} and Hogue, \{Brenda G.\} and Horner, \{Stacy M.\} and Hotez, \{Peter J.\} and Jung, \{Jae U.\} and Kamil, \{Jeremy P.\} and Karst, \{Stephanie M.\} and Lou Laimins and Lakdawala, \{Seema S.\} and Igor Landais and Michael Letko and Brett Lindenbach and Liu, \{Shan Lu\} and Micah Luftig and Grant McFadden and Andrew Mehle and Juliet Morrison and Anne Moscona and Elke M{\"u}hlberger and Joshua Munger and Karl M{\"u}nger and Eain Murphy and Neufeldt, \{Christopher J.\} and Nikolich, \{Janko Z.\} and O'Connor, \{Christine M.\} and Andrew Pekosz and Permar, \{Sallie R.\} and Pfeiffer, \{Julie K.\} and Popescu, \{Saskia V.\} and Purdy, \{John G.\} and Racaniello, \{Vincent R.\} and Rice, \{Charles M.\} and Runstadler, \{Jonathan A.\} and Sapp, \{Martin J.\} and Scott, \{Rona S.\} and Smith, \{Gregory A.\} and Sorrell, \{Erin M.\} and Emily Speranza and Daniel Streblow and Tibbetts, \{Scott A.\} and Zsolt Toth and \{Van Doorslaer\}, Koenraad and Weiss, \{Susan R.\} and White, \{Elizabeth A.\} and White, \{Timothy M.\} and Wobus, \{Christiane E.\} and Michael Worobey and Satoko Yamaoka and Andrew Yurochko",

year = "2024",

month = mar,

doi = "10.1128/jvi.00074-24",

language = "English (US)",

volume = "98",

journal = "Journal of virology",

issn = "0022-538X",

publisher = "American Society for Microbiology",

number = "3",

}

TY - JOUR

T1 - Virology—the path forward

AU - Rasmussen, Angela L.

AU - Gronvall, Gigi K.

AU - Lowen, Anice C.

AU - Goodrum, Felicia

AU - Alwine, James

AU - Andersen, Kristian G.

AU - Anthony, Simon J.

AU - Baines, Joel

AU - Banerjee, Arinjay

AU - Broadbent, Andrew J.

AU - Brooke, Christopher B.

AU - Campos, Samuel K.

AU - Caposio, Patrizia

AU - Casadevall, Arturo

AU - Chan, Gary C.

AU - Cliffe, Anna R.

AU - Collins-McMillen, Donna

AU - Connell, Nancy

AU - Damania, Blossom

AU - Daugherty, Matthew D.

AU - Debbink, Kari

AU - Dermody, Terence S.

AU - DiMaio, Daniel

AU - Duprex, W. Paul

AU - Emerman, Michael

AU - Galloway, Denise A.

AU - Garry, Robert F.

AU - Goldstein, Stephen A.

AU - Greninger, Alexander L.

AU - Hartman, Amy L.

AU - Hogue, Brenda G.

AU - Horner, Stacy M.

AU - Hotez, Peter J.

AU - Jung, Jae U.

AU - Kamil, Jeremy P.

AU - Karst, Stephanie M.

AU - Laimins, Lou

AU - Lakdawala, Seema S.

AU - Landais, Igor

AU - Letko, Michael

AU - Lindenbach, Brett

AU - Liu, Shan Lu

AU - Luftig, Micah

AU - McFadden, Grant

AU - Mehle, Andrew

AU - Morrison, Juliet

AU - Moscona, Anne

AU - Mühlberger, Elke

AU - Munger, Joshua

AU - Münger, Karl

AU - Murphy, Eain

AU - Neufeldt, Christopher J.

AU - Nikolich, Janko Z.

AU - O'Connor, Christine M.

AU - Pekosz, Andrew

AU - Permar, Sallie R.

AU - Pfeiffer, Julie K.

AU - Popescu, Saskia V.

AU - Purdy, John G.

AU - Racaniello, Vincent R.

AU - Rice, Charles M.

AU - Runstadler, Jonathan A.

AU - Sapp, Martin J.

AU - Scott, Rona S.

AU - Smith, Gregory A.

AU - Sorrell, Erin M.

AU - Speranza, Emily

AU - Streblow, Daniel

AU - Tibbetts, Scott A.

AU - Toth, Zsolt

AU - Van Doorslaer, Koenraad

AU - Weiss, Susan R.

AU - White, Elizabeth A.

AU - White, Timothy M.

AU - Wobus, Christiane E.

AU - Worobey, Michael

AU - Yamaoka, Satoko

AU - Yurochko, Andrew

PY - 2024/3

Y1 - 2024/3

N2 - In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.

AB - In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.

KW - biosafety

KW - COVID-19

KW - emergence

KW - oversight

KW - SARS-CoV-2

KW - virology

UR - https://www.scopus.com/pages/publications/85188480137

UR - https://www.scopus.com/pages/publications/85188480137#tab=citedBy

U2 - 10.1128/jvi.00074-24

DO - 10.1128/jvi.00074-24

M3 - Review article

C2 - 38334328

AN - SCOPUS:85188480137

SN - 0022-538X

VL - 98

JO - Journal of virology

JF - Journal of virology

IS - 3

ER -

Virology—the path forward

Abstract

Bibliographical note

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this